Target intelligence / Profile preview

Pathogen-derived toxins

Molecular classification
Enzyme, Pore-forming protein, Lipopolysaccharide, A-B toxin, Other
01

Overview

Pathogen-derived toxins are a broad class of virulence factors produced by microorganisms, including bacteria, fungi, and viruses, that cause damage to host tissues or interfere with normal biological processes (Popoff, 2014). These toxins are generally categorized into exotoxins, which are proteins secreted by living pathogens, and endotoxins, such as lipopolysaccharides, which are released upon the death and lysis of Gram-negative bacteria (StatPearls, 2023). Their mechanisms of action are diverse, involving the disruption of host cell membranes, inhibition of protein synthesis, or the subversion of intracellular signaling pathways to facilitate infection (NIH MeSH). In clinical medicine, these toxins are critical therapeutic targets, particularly in diseases where the toxin is the primary cause of pathology, such as Clostridioides difficile infection, anthrax, and botulism (FDA, 2016). Therapeutic strategies include the use of monoclonal antibodies and antitoxins that neutralize the toxins by blocking their binding to host receptors or preventing their entry into cells (FDA, 2016). While highly effective, the use of these agents can be limited by the timing of administration and potential immunogenic reactions in the patient (StatPearls, 2023).

Other names
Microbial toxinsBacterial toxinsExotoxinsEndotoxinsVirulence factors
02

Mechanism of action

Neutralization of toxin activity by preventing binding to host cell receptors or inhibiting translocation into the cytosol.

03

Biological functions

PathogenesisCell deathImmune response modulationDisruption of cellular homeostasis
04

Disease associations

InfectionSepsisToxic shock syndromeAnthraxBotulismCholera
05

Safety considerations

Hypersensitivity reactionsSerum sicknessDevelopment of anti-drug antibodies (ADAs)Infusion-related reactions
06

Interacting drugs

Bezlotoxumab

4 more in the full profile.

07

Biomarkers

Toxin A/B enzyme immunoassayProtective antigen (PA) serum levelsShiga toxin PCR

Beyond the preview

Go deeper on Pathogen-derived toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen-derived toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call